维普中文期刊产品整合服务
66篇 您的检索式:作者名="Boyett JM"
    题名 作者 年代 出处 被引量
1Lack of Efficacy of Bevacizumab Plus Irinotecan in Children with Recurrent Malignant Glioma and Diffuse Brainstem Glioma:A Pediatric Brain Tumor Consortium Study显示文摘PURPOSE:A phase Ⅱ study of bevacizumab(BVZ) plus irinotecan(CPT-11) was conducted in children with recurrent malignant glioma(MG) and intrinsic brainstem glioma(BSG).PATIENTS AND METHODS:Eligible patients received two doses of BVZGururangan S Chi SN Young Poussaint T Onar-Thomas A Gilbertson RJ Vajapeyam S Friedman HS Packer RJ Rood BN Boyett JM Kun LE 2010中国神经肿瘤杂志2010,8,2:7
2Outcome of treatment in childhood acute lymphoblastic leukemia with rearrangements of the 11q23 chromosomal region 显示文摘Pui CH Gaynon PS Boyett JM 2002Lancet2002,359,9321:1
3Patterns of fail- ure in supratentorial primitive neuroeetodermal tumors trea- ted in Children~ Cancer Group Study 921, a phase ]H com- bined modality study 显示文摘HONG TS MEHTA MP BOYETT JM 2004Int J Radiat Oneol Biol Phys2004,60,1:1
4Combined modality therapy for poorly differentiated gliomas of the posterior fossa in children:a children′s cancer group report显示文摘Bertolone SJ Yates AJ Boyett JM 2003J Neurooncol2003,63,1:1
5Sex differences in prognostic for children with acute lymphoblastic leukemia显示文摘Pui CH Boyett JM Reilling MV 1999Clin Oncol1999,17,3:1
6Blast cell Metho- trexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and Methotrexate dose in acute lymphoblastic leukemia 显示文摘Synold TW Relling MV Boyett JM 1994JClinInvest1994,94,5:1
7Dose pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of childrren with acute lymphoblastic leukemia:what can we learn from small studies显示文摘Evans WE Relling MV Boyett JM 1997Leuk res1997,21,:1
8Chemotherapy for high- grade glion:as of childhood 显示文摘Pollack IF Boyett JM Finlay JL 1999Childs Nerv Syst1999,15,10:1
9Dosepharmacokinetic variability influence the efficacy of high-dosemethotrexate for the treatment of children with acutelymphoblastic leukemia : what can we learn from small studies 显示文摘Evans WE Relling MV Boyett JM 1997Leuk Res1997,21,5:1
10Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphohlastic leukemia : what can we learn from small studies? 显示文摘Evans WE ReUing MV Boyett JM 1997Leuk Res1997,21,5:1
11Prognostic importance of 6-Mercaptopurine dose intensity in acute lymphoblastic leukemia显示文摘Relling MV Kancock ML Boyett JM 1999Blood1999,93,9:1
12Outcome of treatment in child- hood acute lymphoblastic leukemia with rearrangements of the 11 q23 chromosomal region显示文摘Pui CH Gaynon PS Boyett JM 2002Lancet2002,359,9321:1
13Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusion from the Children's Cancer Group 921 randomized phase Ⅲ study 显示文摘Zedtzer PM Boyett JM Finlay Jl 1999J Clin Oncol1999,10,17:1
14Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921,a phase Ⅲ combined modality study显示文摘Hong TS Mehta MP Boyett JM 2004Int J Radiat Oncol Biol Phys2004,60,1:1
15Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization 显示文摘Reardon DA Michalkiewicz E Boyett JM 1997Cancer Res1997,57,18:1
16Dose pharmaeokinetic variability influence the efficacy of high - dose methotrexate for the treatment of chil- dren with acute lymphoblastic leukemia: what can we learn from small studies 显示文摘Evans WE Relling MV Boyett JM 1997Leuk Res1997,21,:1
17Long-term results ofTotal Therapy studies 11,12 and 13A for childhood acutelymphoblastic leukemia at St Jude Children’s ResearchHospital显示文摘Pui CH Boyett JM Ruvera GK 2000Leukemia2000,14,12:1
18Dose pharmacokinetic variability influence the efficacy of highdose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies? 显示文摘Evans WE Relling MV Boyett JM 1997Leuk Res1997,21,:1
19Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children 's Cancer Group 921 randomized phase III study显示文摘Zeltzer PM Boyett JM Finlay JL 1999J Clin Oncol1999,17,3:1
20Outcome of treatment in childhood acute lymphoblastic leukemia with rearrangements of the 11q23 chromosomal region显示文摘Pui CH Gaynon PS Boyett JM 2002Lancet2002,359,9321:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费